Protocol amendments are modifications made to a clinical trial’s protocol after the trial has started. Amendments may be necessary to address changes in study design, methodology, safety measures, or regulatory requirements. All amendments must be reviewed and approved by institutional review boards (IRBs) or ethics committees (ECs) to ensure participant safety and data integrity.